This case study of a Global 500 healthcare company is based on a January 2018 survey of Agari customers by TechValidate, a third-party research service. The profiled company asked to have their name blinded to protect their confidentiality.
We were able to identify and block advanced email attacks that SEGs missed by using Agari Phishing Defense. By using a second vendor for inbound malicious email detection, we reduced the risks for our company.
The company featured in this case study asked to have its name publicly blinded because publicly endorsing vendors is against their policies.
TechValidate stands behind the authenticity of this data.
Company Size: Global 500
Industry: Health Care
The profiled healthcare company evaluated and ultimately selected Agari Phishing Defense to deploy advanced threat protection for email security.
They use Proofpoint as their existing Secure Email Gateway and they chose Agari Phishing Defense to shield themselves from:
The surveyed healthcare company achieved the following results with Agari Phishing Defense:
Rated Agari’s detection and prevention capabilities as follows:
Source: TechValidate survey of a Global 500 Health Care Company
Research by TechValidate